Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.

Siqing Shan, Nicole D. Robson, Yiting Cao, Tong Qiao, Chuan Y. Li, Christopher D. Kontos, Mariano Garcia-Blanco, Mark W. Dewhirst

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Neoplastic cells overexpress several angiogenic cytokines, which stimulate neovascularization. Whether the responses of the host endothelial cells to these signaling molecules affect tumor cells during early tumorigenesis has not been investigated. We investigated pre-angiogenic tumor cell survival and angiogenesis initiation by two murine tumor lines (4T1 mammary carcinoma and B16 melanoma), which constitutively expressed GFP, in dorsal skin-fold window chambers of mice treated with extracellular domain of Tie-2 (ExTek) or bFGF. ExTek reduced tumor cell survival, retarded tumor growth, and inhibited angiogenesis onset compared with controls. bFGF increased tumor cell survival and promoted earlier angiogenesis and tumor growth. Neither bFGF nor ExTek affected cell proliferation in vitro. RT-PCR showed mRNA expression of bFGF receptor 2 (FGFR2) IIIb, which does not bind bFGF efficiently, by 4T1 cells and B16 cells express FGFR1 but not FGFR2. B16 cells expressed angiopoietin (Ang) 2, but neither cell line expresses Ang1. Both tumor lines express VEGF. These findings suggested that effects of bFGF and ExTek on tumor cell survival and angiogenesis were not due to direct action but were instead a result of paracrine factors secreted by endothelial cells. These subsequent signals from endothelial cells promote early survival and proliferation of disseminated tumor cells before onset of angiogenesis.

Original languageEnglish (US)
Pages (from-to)326-328
Number of pages3
JournalThe FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Volume18
Issue number2
StatePublished - 2004
Externally publishedYes

Fingerprint

Endothelial cells
Tumors
Cell Survival
Endothelial Cells
Cells
Neoplasms
Angiopoietin-2
Experimental Melanomas
Cell proliferation
Growth
Vascular Endothelial Growth Factor A
Skin
Carcinogenesis
Cell Proliferation
Breast Neoplasms
Cytokines
Cell Line
Polymerase Chain Reaction
Messenger RNA
Molecules

Cite this

Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. / Shan, Siqing; Robson, Nicole D.; Cao, Yiting; Qiao, Tong; Li, Chuan Y.; Kontos, Christopher D.; Garcia-Blanco, Mariano; Dewhirst, Mark W.

In: The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 18, No. 2, 2004, p. 326-328.

Research output: Contribution to journalArticle

Shan, Siqing ; Robson, Nicole D. ; Cao, Yiting ; Qiao, Tong ; Li, Chuan Y. ; Kontos, Christopher D. ; Garcia-Blanco, Mariano ; Dewhirst, Mark W. / Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. In: The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2004 ; Vol. 18, No. 2. pp. 326-328.
@article{aea8d725bb7849e8a694dc80eaf985b4,
title = "Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.",
abstract = "Neoplastic cells overexpress several angiogenic cytokines, which stimulate neovascularization. Whether the responses of the host endothelial cells to these signaling molecules affect tumor cells during early tumorigenesis has not been investigated. We investigated pre-angiogenic tumor cell survival and angiogenesis initiation by two murine tumor lines (4T1 mammary carcinoma and B16 melanoma), which constitutively expressed GFP, in dorsal skin-fold window chambers of mice treated with extracellular domain of Tie-2 (ExTek) or bFGF. ExTek reduced tumor cell survival, retarded tumor growth, and inhibited angiogenesis onset compared with controls. bFGF increased tumor cell survival and promoted earlier angiogenesis and tumor growth. Neither bFGF nor ExTek affected cell proliferation in vitro. RT-PCR showed mRNA expression of bFGF receptor 2 (FGFR2) IIIb, which does not bind bFGF efficiently, by 4T1 cells and B16 cells express FGFR1 but not FGFR2. B16 cells expressed angiopoietin (Ang) 2, but neither cell line expresses Ang1. Both tumor lines express VEGF. These findings suggested that effects of bFGF and ExTek on tumor cell survival and angiogenesis were not due to direct action but were instead a result of paracrine factors secreted by endothelial cells. These subsequent signals from endothelial cells promote early survival and proliferation of disseminated tumor cells before onset of angiogenesis.",
author = "Siqing Shan and Robson, {Nicole D.} and Yiting Cao and Tong Qiao and Li, {Chuan Y.} and Kontos, {Christopher D.} and Mariano Garcia-Blanco and Dewhirst, {Mark W.}",
year = "2004",
language = "English (US)",
volume = "18",
pages = "326--328",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.

AU - Shan, Siqing

AU - Robson, Nicole D.

AU - Cao, Yiting

AU - Qiao, Tong

AU - Li, Chuan Y.

AU - Kontos, Christopher D.

AU - Garcia-Blanco, Mariano

AU - Dewhirst, Mark W.

PY - 2004

Y1 - 2004

N2 - Neoplastic cells overexpress several angiogenic cytokines, which stimulate neovascularization. Whether the responses of the host endothelial cells to these signaling molecules affect tumor cells during early tumorigenesis has not been investigated. We investigated pre-angiogenic tumor cell survival and angiogenesis initiation by two murine tumor lines (4T1 mammary carcinoma and B16 melanoma), which constitutively expressed GFP, in dorsal skin-fold window chambers of mice treated with extracellular domain of Tie-2 (ExTek) or bFGF. ExTek reduced tumor cell survival, retarded tumor growth, and inhibited angiogenesis onset compared with controls. bFGF increased tumor cell survival and promoted earlier angiogenesis and tumor growth. Neither bFGF nor ExTek affected cell proliferation in vitro. RT-PCR showed mRNA expression of bFGF receptor 2 (FGFR2) IIIb, which does not bind bFGF efficiently, by 4T1 cells and B16 cells express FGFR1 but not FGFR2. B16 cells expressed angiopoietin (Ang) 2, but neither cell line expresses Ang1. Both tumor lines express VEGF. These findings suggested that effects of bFGF and ExTek on tumor cell survival and angiogenesis were not due to direct action but were instead a result of paracrine factors secreted by endothelial cells. These subsequent signals from endothelial cells promote early survival and proliferation of disseminated tumor cells before onset of angiogenesis.

AB - Neoplastic cells overexpress several angiogenic cytokines, which stimulate neovascularization. Whether the responses of the host endothelial cells to these signaling molecules affect tumor cells during early tumorigenesis has not been investigated. We investigated pre-angiogenic tumor cell survival and angiogenesis initiation by two murine tumor lines (4T1 mammary carcinoma and B16 melanoma), which constitutively expressed GFP, in dorsal skin-fold window chambers of mice treated with extracellular domain of Tie-2 (ExTek) or bFGF. ExTek reduced tumor cell survival, retarded tumor growth, and inhibited angiogenesis onset compared with controls. bFGF increased tumor cell survival and promoted earlier angiogenesis and tumor growth. Neither bFGF nor ExTek affected cell proliferation in vitro. RT-PCR showed mRNA expression of bFGF receptor 2 (FGFR2) IIIb, which does not bind bFGF efficiently, by 4T1 cells and B16 cells express FGFR1 but not FGFR2. B16 cells expressed angiopoietin (Ang) 2, but neither cell line expresses Ang1. Both tumor lines express VEGF. These findings suggested that effects of bFGF and ExTek on tumor cell survival and angiogenesis were not due to direct action but were instead a result of paracrine factors secreted by endothelial cells. These subsequent signals from endothelial cells promote early survival and proliferation of disseminated tumor cells before onset of angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=1442265695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442265695&partnerID=8YFLogxK

M3 - Article

C2 - 14688196

AN - SCOPUS:1442265695

VL - 18

SP - 326

EP - 328

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 2

ER -